Eli Lilly & Co. (NYSE:LLY) reported earnings on April 24. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Eli Lilly met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue didn’t move. Non-GAAP earnings per share expanded significantly. GAAP earnings per share grew significantly.
Margins grew across the board.
Eli Lilly & Co. (NYSE:LLY) notched revenue of $5.60 billion. The 12 analysts polled by S&P Capital IQ expected to see a top line of $5.68 billion on the same basis. GAAP reported sales were the same as the prior-year quarter’s.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.14. The 16 earnings estimates compiled by S&P Capital IQ averaged $1.05 per share. Non-GAAP EPS of $1.14 for Q1 were 24% higher than the prior-year quarter’s $0.92 per share. GAAP EPS of $1.42 for Q1 were 56% higher than the prior-year quarter’s $0.91 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 79.3%, 70 basis points better than the prior-year quarter. Operating margin was 25.8%, 70 basis points better than the prior-year quarter. Net margin was 27.6%, 960 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter’s average estimate for revenue is $5.86 billion. On the bottom line, the average EPS estimate is $1.00.
Next year’s average estimate for revenue is $22.96 billion. The average EPS estimate is $3.90.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 1,245 members out of 1,344 rating the stock outperform, and 99 members rating it underperform. Among 425 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 403 give Eli Lilly & Co. (NYSE:LLY) a green thumbs-up, and 22 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Eli Lilly is hold, with an average price target of $54.35.
The article Eli Lilly Beats Analyst Estimates on EPS originally appeared on Fool.com and is written by Seth Jayson.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.